304 related articles for article (PubMed ID: 17142810)
1. Essential role for Co-chaperone Fkbp52 but not Fkbp51 in androgen receptor-mediated signaling and physiology.
Yong W; Yang Z; Periyasamy S; Chen H; Yucel S; Li W; Lin LY; Wolf IM; Cohn MJ; Baskin LS; Sa Nchez ER; Shou W
J Biol Chem; 2007 Feb; 282(7):5026-5036. PubMed ID: 17142810
[TBL] [Abstract][Full Text] [Related]
2. Fkbp52 regulates androgen receptor transactivation activity and male urethra morphogenesis.
Chen H; Yong W; Hinds TD; Yang Z; Zhou Y; Sanchez ER; Shou W
J Biol Chem; 2010 Sep; 285(36):27776-84. PubMed ID: 20605780
[TBL] [Abstract][Full Text] [Related]
3. Targeted ablation reveals a novel role of FKBP52 in gene-specific regulation of glucocorticoid receptor transcriptional activity.
Wolf IM; Periyasamy S; Hinds T; Yong W; Shou W; Sanchez ER
J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):36-45. PubMed ID: 19073255
[TBL] [Abstract][Full Text] [Related]
4. The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms.
Periyasamy S; Warrier M; Tillekeratne MP; Shou W; Sanchez ER
Endocrinology; 2007 Oct; 148(10):4716-26. PubMed ID: 17615153
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52.
Joshi JB; Patel D; Morton DJ; Sharma P; Zou J; Hewa Bostanthirige D; Gorantla Y; Nagappan P; Komaragiri SK; Sivils JC; Xie H; Palaniappan R; Wang G; Cox MB; Chaudhary J
Mol Oncol; 2017 Apr; 11(4):337-357. PubMed ID: 28252832
[TBL] [Abstract][Full Text] [Related]
6. Physiological role for the cochaperone FKBP52 in androgen receptor signaling.
Cheung-Flynn J; Prapapanich V; Cox MB; Riggs DL; Suarez-Quian C; Smith DF
Mol Endocrinol; 2005 Jun; 19(6):1654-66. PubMed ID: 15831525
[TBL] [Abstract][Full Text] [Related]
7. FKBP51 and FKBP52 regulate androgen receptor dimerization and proliferation in prostate cancer cells.
Maeda K; Habara M; Kawaguchi M; Matsumoto H; Hanaki S; Masaki T; Sato Y; Matsuyama H; Kunieda K; Nakagawa H; Shimada M
Mol Oncol; 2022 Feb; 16(4):940-956. PubMed ID: 34057812
[TBL] [Abstract][Full Text] [Related]
8. FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A.
Periyasamy S; Hinds T; Shemshedini L; Shou W; Sanchez ER
Oncogene; 2010 Mar; 29(11):1691-701. PubMed ID: 20023700
[TBL] [Abstract][Full Text] [Related]
9. NF-κB transcriptional activity is modulated by FK506-binding proteins FKBP51 and FKBP52: a role for peptidyl-prolyl isomerase activity.
Erlejman AG; De Leo SA; Mazaira GI; Molinari AM; Camisay MF; Fontana V; Cox MB; Piwien-Pilipuk G; Galigniana MD
J Biol Chem; 2014 Sep; 289(38):26263-26276. PubMed ID: 25104352
[TBL] [Abstract][Full Text] [Related]
10. FKBP51 promotes assembly of the Hsp90 chaperone complex and regulates androgen receptor signaling in prostate cancer cells.
Ni L; Yang CS; Gioeli D; Frierson H; Toft DO; Paschal BM
Mol Cell Biol; 2010 Mar; 30(5):1243-53. PubMed ID: 20048054
[TBL] [Abstract][Full Text] [Related]
11. FKBP51 and FKBP52 in signaling and disease.
Storer CL; Dickey CA; Galigniana MD; Rein T; Cox MB
Trends Endocrinol Metab; 2011 Dec; 22(12):481-90. PubMed ID: 21889356
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Targeting of the FKBP52 Co-Chaperone in Steroid Hormone Receptor-Regulated Physiology and Disease.
Guy NC; Garcia YA; Cox MB
Curr Mol Pharmacol; 2015; 9(2):109-25. PubMed ID: 25986565
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor splice variants are resistant to inhibitors of Hsp90 and FKBP52, which alter androgen receptor activity and expression.
Shafi AA; Cox MB; Weigel NL
Steroids; 2013 Jun; 78(6):548-54. PubMed ID: 23380368
[TBL] [Abstract][Full Text] [Related]
14. The helix 1-3 loop in the glucocorticoid receptor LBD is a regulatory element for FKBP cochaperones.
Cluning C; Ward BK; Rea SL; Arulpragasam A; Fuller PJ; Ratajczak T
Mol Endocrinol; 2013 Jul; 27(7):1020-35. PubMed ID: 23686112
[TBL] [Abstract][Full Text] [Related]
15. Studies of a co-chaperone of the androgen receptor, FKBP52, as candidate for hypospadias.
Beleza-Meireles A; Barbaro M; Wedell A; Töhönen V; Nordenskjöld A
Reprod Biol Endocrinol; 2007 Mar; 5():8. PubMed ID: 17343741
[TBL] [Abstract][Full Text] [Related]
16. Coupling of Conformational Transitions in the N-terminal Domain of the 51-kDa FK506-binding Protein (FKBP51) Near Its Site of Interaction with the Steroid Receptor Proteins.
LeMaster DM; Mustafi SM; Brecher M; Zhang J; Héroux A; Li H; Hernández G
J Biol Chem; 2015 Jun; 290(25):15746-15757. PubMed ID: 25953903
[TBL] [Abstract][Full Text] [Related]
17. FKBP51-a selective modulator of glucocorticoid and androgen sensitivity.
Stechschulte LA; Sanchez ER
Curr Opin Pharmacol; 2011 Aug; 11(4):332-7. PubMed ID: 21565552
[TBL] [Abstract][Full Text] [Related]
18. The FKBP52 Cochaperone Acts in Synergy with β-Catenin to Potentiate Androgen Receptor Signaling.
Storer Samaniego C; Suh JH; Chattopadhyay A; Olivares K; Guy N; Sivils JC; Dey P; Yumoto F; Fletterick RJ; Strom AM; Gustafsson JÅ; Webb P; Cox MB
PLoS One; 2015; 10(7):e0134015. PubMed ID: 26207810
[TBL] [Abstract][Full Text] [Related]
19. The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo.
Riggs DL; Roberts PJ; Chirillo SC; Cheung-Flynn J; Prapapanich V; Ratajczak T; Gaber R; Picard D; Smith DF
EMBO J; 2003 Mar; 22(5):1158-67. PubMed ID: 12606580
[TBL] [Abstract][Full Text] [Related]
20. Differential control of glucocorticoid receptor hormone-binding function by tetratricopeptide repeat (TPR) proteins and the immunosuppressive ligand FK506.
Davies TH; Ning YM; Sánchez ER
Biochemistry; 2005 Feb; 44(6):2030-8. PubMed ID: 15697228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
